Viper ULTRA Thrombolysis Catheter

Viper ULTRA Thrombolysis Catheter

An zaidi infusion catheter maalumu kwa moja kwa moja utoaji wa thrombolytic, akishirikiana mashimo mengi muundo wa kusambaza dawa kwa usawa katika sehemu kubwa za damu.

Habari

The Viper® Ultrasonic Pharmacomechanical Thrombolysis System ni a uvamizi mdogo device designed to dissolve thrombi by combining targeted ultrasonic waves with controlled tPA infusion. By thinning fibrin na increasing clot porosity, the system enables deeper drug penetration into the thrombus, thereby enhancing the efficacy of pharmacological therapy. This approach helps mitigate potential bleeding complications na preserves vessel integrity, offering a more refined, patient-centric strategy for acute thrombosis management.

Ultrasonic Wave Delivery
  • Controlled Ultrasound: Low-power ultrasonic energy focuses on fibrin disruption, loosening the structural integrity of the clot.
  • Enhanced Porosity: Breaking fibrin strands encourages tPA to penetrate deeper, ensuring thorough thrombus dissolution.
  • tPA Administration: A site-specific delivery of tissue plasminogen activator (tPA) directly into the clot.
  • Synergistic Effect: Ultrasonic micro-cavitation augments the fibrinolytic effect, requiring lower drug doses and potentially reducing hemorrhagic complications.
  • Minimal Vessel Trauma: Ultrasonic waves are calibrated to avoid damaging valves, vessel walls, or critical structures within the venous or pulmonary vasculature.
  • Reduced Bleeding Risk: Lower overall drug usage and localized infusion can curtail systemic side effects.
  • Controlled Ultrasound: Low-power ultrasonic energy focuses on fibrin disruption, loosening the structural integrity of the clot.
  • Enhanced Porosity: Breaking fibrin strands encourages tPA to penetrate deeper, ensuring thorough thrombus dissolution.
  • tPA Administration: A site-specific delivery of tissue plasminogen activator (tPA) directly into the clot.
  • Synergistic Effect: Ultrasonic micro-cavitation augments the fibrinolytic effect, requiring lower drug doses and potentially reducing hemorrhagic complications.
  • Minimal Vessel Trauma: Ultrasonic waves are calibrated to avoid damaging valves, vessel walls, or critical structures within the venous or pulmonary vasculature.
  • Reduced Bleeding Risk: Lower overall drug usage and localized infusion can curtail systemic side effects.

Vipimo vya Bidhaa

Vipimo Maelezo / Thamani
Jina la Bidhaa Viper ULTRA Thrombolysis Catheter
Matumizi yaliyokusudiwa Catheter-directed infusion of thrombolytics in acute or subacute thrombus (peripheral, venous, or arterial)
Ubunifu wa Catheter Multi-hole distal segment for uniform drug dispersion, possible radiopaque marker at tip
Nyenzo Pebax/Polyamide shaft, potentially braided or reinforced
Kipenyo cha Nje (F) ~4–6F (depending on infusion lumen capacity)
Urefu wa Kufanya Kazi ~80–150 cm (varies by product code)
Infusion Ports Distributed side ports over a defined segment for consistent thrombolytic delivery
Utangamano wa Mwongozo Typically 0.014” or 0.018”
Kuzaa Tasa, Matumizi Moja
Maisha ya Rafu ~2–3 years if stored at 15–25 °C in sealed packaging
Dalili za Kliniki Thrombolytic infusion for DVT, peripheral arterial occlusions, possibly for intra-graft thrombosis
Contraindications Highly calcified lesions, severe vessel tortuosity preventing safe passage, known device material allergies

Matrix ya Kuagiza & Ukubwa

Kipenyo cha Nje (F) Urefu wa Kufanya kazi (cm) Infusion Segment (cm) Kanuni ya Bidhaa Vidokezo
4F 80 10 VPR-4F-80-10 Smaller OD for distal or small vessel usage
4F 120 15 VPR-4F-120-15 Longer shaft, moderate infusion segment
5F 80 10 VPR-5F-80-10 Slightly larger OD for heavier clot load
5F 120 20 VPR-5F-120-20 Extended length with longer infusion zone
6F 100 15 VPR-6F-100-15 Common size for multi-level peripheral lesions
6F 150 30 VPR-6F-150-30 Max length, extensive infusion segment

Bidhaa zinazohusiana